Skip to main content
Equibles

HELP · Cybin Inc. · Metrics

Track HELP — free

Use HELP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HELP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.97 +0.13 (+1.01%) At close · Sep 11
Rebalance outlook locked
Market Cap
$947.59M
Shares
73.06M

HELP metrics

33 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.97
Market cap
$947.59M

Price action

20 metrics
Price change (1W)
+6.1%
Price change (30D)
+13.3%
Price change (3M)
+201.6%
Price change (6M)
+179.5%
Price change (YTD)
+58.6%
Price change (1Y)
+115.8%
Trailing year
Price change (5Y)
—
52-week high
$13.99
52-week low
$3.87
Change from 52-week high
-7.3%
Change from 52-week low
+235.1%
Annualized volatility
83.7%
Annualized volatility (3M)
91.2%
Beta
2.2
RSI (14D)
60.4
Price vs SMA 50
+31.7%
Price vs SMA 200
+88.2%
Avg volume (3M)
1.71M
Relative volume
0.7
Average dollar volume
$15.65M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
73.06M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-11-13

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
—
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
—
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
99
13F filer change QoQ
+17
Institutional ownership
42.2%

Short interest

3 metrics
Short interest
4.1%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
$8.28M
Insider-sentiment score
95 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1833141 CUSIP 23256X407 13F (30d) 49 filings 49 filers Visit website Investor relations